National Vice President, Respiratory Technologies
San Diego, Ca, Us
Revenue & GP responsibility for $190M capital, consumables, analytics software and services business serving intensive care, post-acute, and physician office segments. Led strategic shift while outperforming industry peers in a highly regulated FDA Class 2/3 segment. 5-channel commercial organization of direct and indirect sales (145 total personnel)►Delivered 100% and 106% of budget, 4% and 12% annual growth (organic) vs. market CAGR of +/-2%, overcoming product recalls and competitive product launches; Improved revenue productivity 20%►Drove strategic shift to “solutions” model incorporating device interoperability and software analytics, redefined basis of competition, elevated the sale to C-level►Refined commercial offerings to include SAAS, rental, leasing, and upgrades►Directed improved selling tools to differentiate offerings, enhance competitive positioning►Restructured organization to facilitate cross-selling and clinical sales alignment, enabling 23% more customer touches and reducing T&E by $240k►Streamlined operational cadence, improved field communication, decreased managers’ time 50%, improved forecast accuracy 22%►Overhauled quota & compensation process; aligned incentives to growth drivers, improved quota achievement 35%, reduced errors by 90%, improved satisfaction from 40% to 95%►Partnered with IT to lead deployment of modern CRM/CPQ systems, improving productivity, professionalism, and compliance►Installed system that ensured solid manager feedback against meaningful development objectives, reliable KPIs, comprehensive 360-degree reviews, and defined succession paths for all key roles►Championed efforts that sustainably improved culture to embrace transparency, accountability, and teamwork►Redesigned hiring & training model to improve talent & develop skills. Decreased turnover 65%. ►Installed Challenger selling process to enable strategic shift; aligned downstream marketing to facilitate organizational uptake and execution